Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Fertil Steril ; 90(5): 1805-11, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17961560

RESUMO

OBJECTIVE: To assess sexual function in women with spontaneous 46,XX primary ovarian insufficiency after at least 3 months of a standardized hormone replacement regimen. DESIGN: Cross-sectional cohort, controlled. SETTING: National Institutes of Health Clinical Research Center. PATIENT(S): Women with primary ovarian insufficiency (n = 143) and regularly menstruating controls (n = 70). INTERVENTION(S): Self-administered questionnaires, 100 microg/day E(2) patch, oral medroxyprogesterone acetate 10 mg for 12 days each month for patients. MAIN OUTCOME MEASURE(S): Derogatis Interview for Sexual Function Self-Report (DISF-SR). RESULT(S): Women with primary ovarian insufficiency had significantly lower DISF-SR composite scores compared with control women. Their serum total testosterone levels were significantly correlated with DISF-SR composite score, although this accounted for only 4% of the variance in this measure. Patients with testosterone levels below normal tended to have lower DISF-SR composite scores. Of patients with primary ovarian insufficiency, 9 of 127 (7%) scored below the second percentile on the composite sexual function score, compared with 1 of 49 control women (2%). CONCLUSION(S): As assessed by the DISF-SR, sexual function is in the normal range for most young women with 46,XX spontaneous primary ovarian insufficiency who are receiving physiologic E(2) replacement. However, as a group, these young women score significantly lower on this sexual function scale than control women.


Assuntos
Terapia de Reposição de Estrogênios , Disgenesia Gonadal 46 XX/complicações , Insuficiência Ovariana Primária/tratamento farmacológico , Comportamento Sexual/efeitos dos fármacos , Disfunções Sexuais Fisiológicas/prevenção & controle , Administração Cutânea , Administração Oral , Adulto , Estudos Transversais , Método Duplo-Cego , Estrogênios/administração & dosagem , Feminino , Disgenesia Gonadal 46 XX/genética , Humanos , Acetato de Medroxiprogesterona/administração & dosagem , Insuficiência Ovariana Primária/genética , Insuficiência Ovariana Primária/fisiopatologia , Estudos Prospectivos , Disfunções Sexuais Fisiológicas/genética , Disfunções Sexuais Fisiológicas/fisiopatologia , Inquéritos e Questionários , Testosterona/sangue , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA